Web3 Content Creator & Producer // Marketing Advisor & Coordinator + Community Builder // FB Groups + Discord Expert
What's Going On In Web3 | October 19, 2022
Here’s the headlines you probably missed from yesterday, and a few from this morning. We’ll be talking about this and more during today’s MindfulGMs at 9:30 AM CST on Twitter. Here’s the link: https://twitter.com/i/spaces/1ynJOabXREQKR?s=20IRS 2022 Tax Guidelines to Treat NFTs as Stablecoins, Cryptocurrencieshttps://decrypt.co/112367/irs-2022-tax-guidelines-treat-nfts-stablecoins-cryptocurrenciesSame rules as crypto: if you sell, exchange, gift, or transfer you pay capital gains taxIf you rec...
What's Going On In Web3 | October 19, 2022
Here’s the headlines you probably missed from yesterday, and a few from this morning. We’ll be talking about this and more during today’s MindfulGMs at 9:30 AM CST on Twitter. Here’s the link: https://twitter.com/i/spaces/1ynJOabXREQKR?s=20IRS 2022 Tax Guidelines to Treat NFTs as Stablecoins, Cryptocurrencieshttps://decrypt.co/112367/irs-2022-tax-guidelines-treat-nfts-stablecoins-cryptocurrenciesSame rules as crypto: if you sell, exchange, gift, or transfer you pay capital gains taxIf you rec...
What's going on in web3? #8 | July 29, 2022
Martin Shkreli debuts web3 drug companyProof-of-Optimization Flowchart from Druglike's whitepaperPharma bro Martin Shkreli, fresh out of prison, has been working non-stop over the last few months on a web3 drug company that seeks to disrupt the silicone valley early-stage drug investment game. The company, Druglike, dubs itself “a platform for democratizing the access, costs, and rewards of early-stage drug discovery.” At the heart of the technology is what the company refers to as a “pr...
What's going on in web3? #8 | July 29, 2022
Martin Shkreli debuts web3 drug companyProof-of-Optimization Flowchart from Druglike's whitepaperPharma bro Martin Shkreli, fresh out of prison, has been working non-stop over the last few months on a web3 drug company that seeks to disrupt the silicone valley early-stage drug investment game. The company, Druglike, dubs itself “a platform for democratizing the access, costs, and rewards of early-stage drug discovery.” At the heart of the technology is what the company refers to as a “pr...
